$195.03
+7.14 (+3.80%)
At Close: Jun 03, 2026
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025
10:00am, Thursday, 06'th Mar 2025
DENVER , March 6, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will
YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities
09:00am, Thursday, 27'th Feb 2025
CHICAGO and DENVER, Feb. 27, 2025 (GLOBE NEWSWIRE) -- YMCA of the USA (Y-USA), the national resource office for the 2,600+ YMCAs across the country, is excited to expand its collaboration with DaVita,
Here's why this Warren Buffett stock plunged 11% in a day
08:13am, Monday, 17'th Feb 2025
Shares of Davita Inc. (NYSE: DVA) plunged 11% on February 14, as the dialysis provider issued a weaker-than-expected 2025 earnings outlook, citing rising patient care costs, supply constraints, and on
Why DaVita Inc Stock Is Plummeting Today
05:25pm, Friday, 14'th Feb 2025
Shares of DaVita Inc (DVA -11.09%) are trading lower on Friday. The company's stock lost 11.1% as of market close but lost as much as 15.2% earlier in the day.
DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.
01:01pm, Friday, 14'th Feb 2025
DaVita shares were tumbling 13.5% Friday to lead S&P 500 decliners, after Warren Buffett's Berkshire Hathaway pared its stake in the provider of kidney dialysis.
Here's why Warren Buffett dumped $31 million worth of this stock
08:41am, Friday, 14'th Feb 2025
Warren Buffett, the ‘Oracle of Omaha', managed to attain a roughly $142 billion net worth by consistently outperforming the markets. The Berkshire Hathaway (NYSE: BRK.B) chief executive officer (CEO
Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance
08:16am, Friday, 14'th Feb 2025
DaVita shares tumbled after issuing a weak outlook amid rising care costs, while big investor Berkshire offloaded some shares in a pre-planned agreement.
DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript
08:19pm, Thursday, 13'th Feb 2025
DaVita Inc. (NYSE:DVA ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Partici
Berkshire sells some DaVita shares, cuts stake to 45%
08:13pm, Thursday, 13'th Feb 2025
Berkshire Hathaway said on Thursday night it sold 203,091 shares of DaVita , reducing its stake in the kidney dialysis services provider to about 35.89 million shares, a 45% stake worth nearly $6.4 bi
DaVita HealthCare (DVA) Beats Q4 Earnings and Revenue Estimates
06:21pm, Thursday, 13'th Feb 2025
DaVita HealthCare (DVA) came out with quarterly earnings of $2.24 per share, beating the Zacks Consensus Estimate of $2.21 per share. This compares to earnings of $1.87 per share a year ago.
DaVita forecasts 2025 profit below estimates, shares plummet
06:07pm, Thursday, 13'th Feb 2025
Dialysis firm DaVita projected annual profit below estimates on Thursday due to rising patient care costs, sending its shares down 11% in after-hours trading.
DaVita Inc. 4th Quarter 2024 Results
04:05pm, Thursday, 13'th Feb 2025
DENVER , Feb. 13, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended December 31, 2024. "Despite a year with unique hurdles, we finished stron
DVA Q4 Estimates Unchanged Before Earnings: How to Play the Stock?
11:31am, Wednesday, 12'th Feb 2025
Continued strength in RPT is likely to have boosted DaVita's top line in the fourth quarter despite supply challenges weighing on its performance.
DaVita HealthCare (DVA) Increases Yet Falls Behind Market: What Investors Need to Know
07:05pm, Tuesday, 04'th Feb 2025
The latest trading day saw DaVita HealthCare (DVA) settling at $177.35, representing a +0.16% change from its previous close.
2 Warren Buffett Stocks to Buy Without Hesitation If You Have $1,000 to Invest Right Now
10:00am, Sunday, 02'nd Feb 2025
The Oracle of Omaha, Warren Buffett, is arguably one of the most famous investors of all time. Many investors have sought to replicate his investing strategy as emphasized by the holdings of Buffett's
Sign In
Buy DVA